HEADER IMMUNE SYSTEM 30-APR-99 1GYF TITLE GYF DOMAIN FROM HUMAN CD2BP2 PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (CYTOPLASMIC DOMAIN BINDING PROTEIN (CD2BP2)); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CD2-BINDING DOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: T-LYMPHOCYTE; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTFT74 KEYWDS T CELL SIGNALING, PROLINE-RICH SEQUENCE RECOGNITION, ADAPTER DOMAIN, KEYWDS 2 IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 16 AUTHOR C.FREUND,V.DOETSCH,K.NISHIZAWA,E.L.REINHERZ,G.WAGNER REVDAT 5 27-DEC-23 1GYF 1 REMARK REVDAT 4 23-FEB-22 1GYF 1 REMARK REVDAT 3 24-FEB-09 1GYF 1 VERSN REVDAT 2 01-APR-03 1GYF 1 JRNL REVDAT 1 05-JAN-00 1GYF 0 JRNL AUTH C.FREUND,V.DOTSCH,K.NISHIZAWA,E.L.REINHERZ,G.WAGNER JRNL TITL THE GYF DOMAIN IS A NOVEL STRUCTURAL FOLD THAT IS INVOLVED JRNL TITL 2 IN LYMPHOID SIGNALING THROUGH PROLINE-RICH SEQUENCES. JRNL REF NAT.STRUCT.BIOL. V. 6 656 1999 JRNL REFN ISSN 1072-8368 JRNL PMID 10404223 JRNL DOI 10.1038/10712 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GYF COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAY-99. REMARK 100 THE DEPOSITION ID IS D_1000000983. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.3 REMARK 210 IONIC STRENGTH : 50 MM NAPO4 REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : 90% WATER/10%D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 15N-NOESY; 13C-NOESY; REMARK 210 15N-TOCSY; HCCH-TOCSY; HNCA; REMARK 210 CBCACONH; HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 600 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AMX500; VXR500; UNITY500; REMARK 210 UNITYPLUS750 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, DYANA, X-PLOR REMARK 210 METHOD USED : DISTANCE GEOMETRY REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 16 REMARK 210 CONFORMERS, SELECTION CRITERIA : LEAST RESTRAINT VIOLATIONS, REMARK 210 LEAST ENERGY FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 6 REMARK 210 REMARK 210 REMARK: LOWEST ENERGY. NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 51 H GLU A 55 1.55 REMARK 500 H TYR A 30 O TYR A 41 1.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 41 -156.50 -141.80 REMARK 500 1 PHE A 82 30.39 -98.59 REMARK 500 1 LEU A 84 30.56 -147.02 REMARK 500 1 TYR A 85 -52.04 -138.54 REMARK 500 2 GLU A 39 -174.58 -58.56 REMARK 500 2 TYR A 41 -162.55 -114.05 REMARK 500 2 GLN A 73 66.36 -115.03 REMARK 500 2 PHE A 74 -172.67 45.09 REMARK 500 2 TYR A 75 113.39 179.63 REMARK 500 2 PHE A 82 35.53 -96.70 REMARK 500 2 LEU A 84 30.00 -146.51 REMARK 500 2 TYR A 85 -53.05 -133.53 REMARK 500 3 GLU A 39 -177.50 -60.46 REMARK 500 3 GLN A 73 65.42 64.74 REMARK 500 3 PHE A 74 -178.09 -55.64 REMARK 500 3 PHE A 82 38.44 -97.47 REMARK 500 3 ASP A 83 30.73 -143.60 REMARK 500 3 LEU A 84 30.95 -147.50 REMARK 500 3 TYR A 85 -49.98 -136.33 REMARK 500 4 GLU A 39 -177.64 -61.96 REMARK 500 4 TYR A 41 -158.04 -121.00 REMARK 500 4 GLN A 73 70.37 -114.11 REMARK 500 4 PHE A 74 166.71 56.48 REMARK 500 4 TYR A 75 114.97 -174.05 REMARK 500 4 LEU A 84 30.05 -144.88 REMARK 500 4 TYR A 85 -52.96 -138.10 REMARK 500 5 VAL A 26 97.36 -64.47 REMARK 500 5 ASN A 34 51.46 -90.46 REMARK 500 5 GLU A 39 -177.46 -56.34 REMARK 500 5 TYR A 41 -162.98 -111.33 REMARK 500 5 LEU A 84 29.27 -144.92 REMARK 500 5 TYR A 85 -46.58 -140.54 REMARK 500 6 TYR A 41 -164.39 -113.36 REMARK 500 6 PHE A 58 75.81 -117.27 REMARK 500 6 GLN A 73 65.93 -112.22 REMARK 500 6 PHE A 74 104.30 48.61 REMARK 500 6 LEU A 84 29.42 -145.82 REMARK 500 6 TYR A 85 -56.94 -143.65 REMARK 500 7 ALA A 38 159.20 -43.33 REMARK 500 7 GLU A 39 -177.07 -57.22 REMARK 500 7 LEU A 40 84.33 -157.13 REMARK 500 7 TYR A 41 -162.57 -114.81 REMARK 500 7 PHE A 58 78.73 -114.00 REMARK 500 7 GLN A 73 71.19 -109.29 REMARK 500 7 PHE A 74 155.16 59.22 REMARK 500 7 TYR A 75 107.62 -161.37 REMARK 500 7 LEU A 84 30.51 -145.28 REMARK 500 7 TYR A 85 -49.50 -133.34 REMARK 500 8 THR A 35 -166.85 -101.95 REMARK 500 8 ALA A 38 154.81 -44.14 REMARK 500 REMARK 500 THIS ENTRY HAS 124 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1GYF A 25 86 UNP O95400 CD2B2_HUMAN 280 341 SEQRES 1 A 62 ASP VAL MET TRP GLU TYR LYS TRP GLU ASN THR GLY ASP SEQRES 2 A 62 ALA GLU LEU TYR GLY PRO PHE THR SER ALA GLN MET GLN SEQRES 3 A 62 THR TRP VAL SER GLU GLY TYR PHE PRO ASP GLY VAL TYR SEQRES 4 A 62 CYS ARG LYS LEU ASP PRO PRO GLY GLY GLN PHE TYR ASN SEQRES 5 A 62 SER LYS ARG ILE ASP PHE ASP LEU TYR THR HELIX 1 1 SER A 46 GLU A 55 1 10 HELIX 2 2 SER A 77 ARG A 79 5 3 SHEET 1 A 2 TRP A 28 LYS A 31 0 SHEET 2 A 2 TYR A 63 LYS A 66 -1 N ARG A 65 O GLU A 29 CISPEP 1 ASP A 68 PRO A 69 1 0.08 CISPEP 2 ASP A 68 PRO A 69 2 0.01 CISPEP 3 ASP A 68 PRO A 69 3 0.08 CISPEP 4 ASP A 68 PRO A 69 4 -0.01 CISPEP 5 ASP A 68 PRO A 69 5 0.01 CISPEP 6 ASP A 68 PRO A 69 6 0.02 CISPEP 7 ASP A 68 PRO A 69 7 -0.06 CISPEP 8 ASP A 68 PRO A 69 8 0.10 CISPEP 9 ASP A 68 PRO A 69 9 0.06 CISPEP 10 ASP A 68 PRO A 69 10 0.03 CISPEP 11 ASP A 68 PRO A 69 11 0.09 CISPEP 12 ASP A 68 PRO A 69 12 0.02 CISPEP 13 ASP A 68 PRO A 69 13 -0.03 CISPEP 14 ASP A 68 PRO A 69 14 -0.09 CISPEP 15 ASP A 68 PRO A 69 15 -0.09 CISPEP 16 ASP A 68 PRO A 69 16 0.09 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1